The Week in Health: Treatable Deaths, Healthtech Growth, and AI

This week, new regional and national data put Mexico's health outcomes under scrutiny. An OECD, IDB, and World Bank report places the country's treatable mortality above the Latin American average, and INEGI figures confirm heart disease as the leading cause of death. The digital health ecosystem is shifting from experimentation to scale, with interoperability now ranked as its main competitive differentiator. Meanwhile, experts examine how AI is changing both the patient journey and the definition of medical excellence. They also make the case for treating corporate health as financial infrastructure and point to the opportunities that medical tourism and an aging population create for providers and manufacturers.

Ready? This is the Week in Health!

Mexico's Digital Health Sector Grows 300%, Shifts Focus to Scale
Mexico's digital health sector has grown 300% since 2022 and now includes more than 100 startups, according to the HealthTech Mexico Association's Radar 2026. The report ranks interoperability above the development of new solutions as the ecosystem's main differentiator over the next five years. Demand for integration is rising for three reasons. The Universal Health Service plans to begin inter-institutional service exchange on Jan. 1, 2027. The General Health Law reform formalizes digital health and AI use. IMSS, ISSSTE, and IMSS-Bienestar are working to connect separate record systems. The association identifies interoperability, digital infrastructure, specialized talent, and data governance as the sector's main barriers.

PAHO Trains Over 360 on the Use of the Air Pollution Health Tool
More than 360 participants from 24 Mexican states joined the AirQ+ Marathon webinar. PAHO/WHO organized it with the Ministry of Health and SEMARNAT to strengthen capacity to measure the health effects of air pollution. Specialists from INSP presented applications of the WHO tool, and the Queretaro Ministry of Health shared its experience using AI-free modeling of local air quality evidence to prioritize public health needs. Mexico's session was part of a regional initiative with 12 activities in nine countries. According to PAHO, air pollution causes about 411,000 premature deaths in the Americas each year.

Heart Disease: Leading Cause of Death in Mexico
Heart disease caused 177,673 of Mexico's 762,494 registered deaths in 2025, about 23% of the total, according to preliminary INEGI data. Ahead of World Heart Day, the Association for Children's Hearts (ACORI) is calling for wider neonatal cardiac screening, including pulse oximetry, to detect congenital heart disease earlier. Federal cardiovascular policy, through the HEARTS initiative and the newly mandatory PRONAM protocols, focuses mainly on adult cardio-renal-metabolic care. Neither framework includes congenital heart disease screening. ENSANUT data also show that 36.6% of children aged five to 11 live with overweight or obesity.

Mexico's Treatable Mortality Rate Exceeds Regional Average: OECD
Mexico records 135 treatable deaths per 100,000 inhabitants. That is above the average of 130 across 33 Latin American and Caribbean countries and more than double the OECD's 57, according to Health at a Glance: Latin America and the Caribbean 2026 by the OECD, IDB, and World Bank. The country also exceeds the regional average for preventable mortality. It relies on voluntary adverse event reporting and lacks a formal physician accreditation program. The findings come as public institutions implement mandatory PRONAM protocols and as the Ministry of Health and PAHO/WHO advance their 2026–2030 cooperation strategy.

Expert Contributors

The Three Disconnections That Are Making Us Sick
María Jesús Salido, Founder, SocialDiabetes & Listen.Doctor, argues that sustained workplace stress among founders and executives is a systemic health hazard rather than a personal trait. She cites a UCSF study in which 49% of entrepreneurs reported a mental health condition, against 32% of a comparison group. She also cites WHO and ILO estimates that long working hours caused 745,000 deaths in 2016. Salido identifies three disconnections: from the body, through accumulated allostatic load; from purpose, through burnout; and from silence, as average screen attention has fallen to 47 seconds. She calls for redesigning working conditions instead of relying on individual wellness programs.

Asking AI About Health Isn't the Risk. The Risk Is Stopping There
Adrián Alcántara, CEO, Doctoralia Mexico, notes that Google displays AI-generated summaries in up to 92% of health-related searches, according to Stanford HAI. He argues that the challenge is not to stop people from consulting AI but to connect that information with professional care, since a clear answer may still lack clinical context. As part of its ninth anniversary in Mexico, Doctoralia is launching Nova, an AI agent that matches patients with professionals and schedules appointments. Nova also helps patients manage their medical records. Alcántara says the tool does not diagnose or replace medical judgment.

From Benefit to Infrastructure: The Shift Mexico Is Missing
Rafael Lopez Schietekat, Cofounder and CEO, Diagnostikare, argues that Mexican companies should treat corporate health as operational infrastructure decided by CFOs and boards, not as an HR benefit. He points to projected 2026 medical inflation of 14.8%, according to Aon, and to burnout reported by 72% of employees, according to Buk. He also notes that only 27% of companies conduct formal psychosocial risk evaluations under NOM-035. He warns that frameworks such as ISO 45003 and the EU's Corporate Sustainability Reporting Directive will reach Mexican suppliers through multinational value chains.

What Makes a Great Doctor: How AI Is Redefining Excellence
Jorge Camargo, Founder, Ecaresoft, proposes a thought experiment on how AI could change which physicians stand out. If AI narrows differences in medical knowledge recall, he argues, other abilities may gain weight: obtaining reliable information from patients and turning decisions into effective care. Camargo adds that physicians will need new skills, such as deciding what to delegate and detecting unsupported conclusions. He suggests that some of healthcare's largest changes may come from reorganizing care around a new distribution of abilities across professions.

Medical Tourism: Reimagining Healthcare Beyond Borders
Alejandro Torres Martinez, CEO, Auna Mexico, writes ahead of the 2026 International Medical Tourism Congress (CITURMED), held at Doctors Hospital Auna in Monterrey. He argues that patient-centered care, not cost alone, now drives medical tourism. He adds that complex procedures such as joint replacements can be delivered at 40% to 70% lower cost than in the United States. Torres notes that Mexico received an estimated 1.3 million international patients annually before the pandemic. He calls on providers, government, academia, and the tourism industry to build a unified national brand.

What Mexican Doctors Can Learn From Their Latin American Peers
Enrique Culebro, CEO, Central Media, presents the Médic@ Digital en Latinoamérica 2026 study, developed with FUNSALUD and validated by Mexico's National Academy of Medicine. More than 4,000 physicians in Mexico, Colombia, Peru, Chile, and Argentina answered the same questionnaire. It covers digital habits, patient contact, electronic records and e-prescriptions, AI use, social platforms, and relationships with the pharmaceutical industry. The 2024 edition found that only one in 10 Mexican doctors used AI tools. Results of the new edition will be presented on Oct. 7.

Medical Devices and Healthcare Opportunities for Aging Trends
Marcos Pascual, General Director, Asesoría en Farmacias, argues that Mexico's aging population and rising chronic disease burden create an opportunity for its medical device industry. He notes that the country accounts for 8.66% of global manufacturing output in the sector and generates US$22 billion in annual revenue. Pascual highlights colorectal cancer screening from age 45, a group of about 8 million people aged 45 to 49, using immunochemical fecal occult blood tests. Timely screening can reduce mortality by 30% to 60%. He also points to growing demand for eldercare infrastructure and continuous care devices.